199 related articles for article (PubMed ID: 11001911)
41. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.
Wang J; Hoshino T; Redner RL; Kajigaya S; Liu JM
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10860-5. PubMed ID: 9724795
[TBL] [Abstract][Full Text] [Related]
42. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.
Gelmetti V; Zhang J; Fanelli M; Minucci S; Pelicci PG; Lazar MA
Mol Cell Biol; 1998 Dec; 18(12):7185-91. PubMed ID: 9819405
[TBL] [Abstract][Full Text] [Related]
43. Frequency of ETV6/AML1 fusion in adult acute lymphoblastic leukemia.
Cuneo A; Agostini P; Vitale A; Foà R; Castoldi G
Leukemia; 2003 Feb; 17(2):476-7; author reply 477. PubMed ID: 12592356
[No Abstract] [Full Text] [Related]
44. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia.
Raynaud S; Mauvieux L; Cayuela JM; Bastard C; Bilhou-Nabera C; Debuire B; Bories D; Boucheix C; Charrin C; Fière D; Gabert J
Leukemia; 1996 Sep; 10(9):1529-30. PubMed ID: 8751475
[No Abstract] [Full Text] [Related]
45. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.
Fenrick R; Amann JM; Lutterbach B; Wang L; Westendorf JJ; Downing JR; Hiebert SW
Mol Cell Biol; 1999 Oct; 19(10):6566-74. PubMed ID: 10490596
[TBL] [Abstract][Full Text] [Related]
46. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG
Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587
[TBL] [Abstract][Full Text] [Related]
47. Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression.
Fears S; Chakrabarti SR; Nucifora G; Rowley JD
Cancer Genet Cytogenet; 2002 Jun; 135(2):110-9. PubMed ID: 12127395
[TBL] [Abstract][Full Text] [Related]
48. Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter.
Uchida H; Downing JR; Miyazaki Y; Frank R; Zhang J; Nimer SD
Oncogene; 1999 Jan; 18(4):1015-22. PubMed ID: 10023677
[TBL] [Abstract][Full Text] [Related]
49. The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Whitehead VM; Payment C; Cooley L; Lauer SJ; Mahoney DH; Shuster JJ; Vuchich MJ; Bernstein ML; Look AT; Pullen DJ; Camitta B
Leukemia; 2001 Jul; 15(7):1081-8. PubMed ID: 11455977
[TBL] [Abstract][Full Text] [Related]
50. ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.
Stoskus M; Vaitkeviciene G; Eidukaite A; Griskevicius L
Blood Cells Mol Dis; 2016 Mar; 57():30-4. PubMed ID: 26852652
[TBL] [Abstract][Full Text] [Related]
51. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.
Bernardin F; Yang Y; Cleaves R; Zahurak M; Cheng L; Civin CI; Friedman AD
Cancer Res; 2002 Jul; 62(14):3904-8. PubMed ID: 12124316
[TBL] [Abstract][Full Text] [Related]
52. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
53. Functional characterization of TEL/AML1 fusion protein in the regulation of human CR1 gene promoter.
Song H; Kim JH; Rho JK; Park SY; Kim CG; Choe SY
Mol Cells; 1999 Oct; 9(5):560-3. PubMed ID: 10597047
[TBL] [Abstract][Full Text] [Related]
54. Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals.
Eguchi-Ishimae M; Eguchi M; Ishii E; Miyazaki S; Ueda K; Kamada N; Mizutani S
Blood; 2001 Feb; 97(3):737-43. PubMed ID: 11157492
[TBL] [Abstract][Full Text] [Related]
55. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
Peter A; Heiden T; Taube T; Körner G; Seeger K
Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
[TBL] [Abstract][Full Text] [Related]
56. ETV6-AML1 translocation breakpoints cluster near a purine/pyrimidine repeat region in the ETV6 gene.
Thandla SP; Ploski JE; Raza-Egilmez SZ; Chhalliyil PP; Block AW; de Jong PJ; Aplan PD
Blood; 1999 Jan; 93(1):293-9. PubMed ID: 9864173
[TBL] [Abstract][Full Text] [Related]
57. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
[TBL] [Abstract][Full Text] [Related]
58. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies.
Chakrabarti SR; Sood R; Nandi S; Nucifora G
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13281-5. PubMed ID: 11078523
[TBL] [Abstract][Full Text] [Related]
59. Domains involved in ETO and human N-CoR interaction and ETO transcription repression.
Wang J; Wang M; Liu JM
Leuk Res; 2004 Apr; 28(4):409-14. PubMed ID: 15109542
[TBL] [Abstract][Full Text] [Related]
60. The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications.
Asou N
Crit Rev Oncol Hematol; 2003 Feb; 45(2):129-50. PubMed ID: 12604126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]